Navigation Links
Epitomics receives ISO 9001 certification for the production of Rabbit Monoclonal Antibodies.
Date:5/6/2008

BURLINGAME, Calif., May 6 /PRNewswire/ -- Epitomics, Inc. announced today that its Hangzhou subsidiary has received ISO 9001-2000 certification for the development and production of its novel line of rabbit monoclonal antibodies. "This certification demonstrates our commitment to establishing a standard for quality management and ultimately the finest quality antibodies available to meet our customers' needs." said Dr. Guo-Liang Yu, President and CEO of Epitomics, Inc.

"ISO certification is a very important milestone for the company and an independent validation of our quality system to ensure high quality products for our customers" said Dr. Y. Peter Li, Senior VP of Product Development for Epitomics. The ISO standard provides common worldwide criteria for effective quality management and covers twenty areas including design, document control, inspection, testing, servicing and training. ISO 9001 certification is received upon successful completion of an accredited third party audit and provides independent validation that Epitomics quality management system meets the high standard of quality set forth by the International Organization for Standardization (ISO).

Epitomics Hangzhou facility is involved with the design and manufacture of Epitomics' proprietary RabMAbs(TM) (Rabbit Monoclonal Antibodies) for research, diagnostic and therapeutic applications. With ISO certification, Epitomics will continue updating and refining its' quality management processes and procedures to provide customers with the best quality antibodies available.

About Epitomics

Epitomics, Inc., an emerging biotechnology company, is dedicated to developing its breakthrough rabbit monoclonal antibody technology for research, diagnostic and therapeutic applications. The Company utilizes a unique and proprietary RabMAb(TM) (Rabbit Monoclonal Antibody) technology which produces antibodies with superior binding affinity and bioactivity in a wide variety of biological assays. The Company is headquartered in Burlingame, California, and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. More information about Epitomics can be found at http://www.epitomics.com


'/>"/>
SOURCE Epitomics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NBCHs Community Coalitions Health Institute Receives CDC Grant
2. Weill Cornell receives funding to study creation of new elder abuse center
3. Cadient Group Continues Winning Streak; Receives Multiple Honors at 2008 Pharmaceutical Advertising and Marketing Excellence Awards
4. AACR CEO receives Distinguished Public Service Award
5. HeartWare Receives Conditional Approval of IDE
6. Courage Center Receives $150,000 Grant From Minneapolis Foundation
7. Sentillion Receives U.S. Patent for Administering Context Management Systems
8. LMS CALM(R) receives high customer satisfaction scores in the 2008 KLAS Labor and Delivery report
9. Derma Sciences Receives Third FDA Clearance for MEDIHONEY(TM) Wound & Burn Dressings
10. Inscent, Inc. Receives Federal Grant to Develop Honeybee Repellents
11. Milan Fiala, MD, receives 2008 Alzheimer Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald E. Hawkins, ... the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the ... April 10. Dr. Bell comes to Liberty from the Ohio University Heritage College ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... 24, 2017 , ... Indiana Fiber Network (IFN) President and CEO Kelly C. ... Dyer started as the Chairman of the Management Committee when IFN was originally formed ... the recruitment of investor/owners and development of the business plan. He became the ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... 2017 partnership with The Jensie Gran Fondo of Marin. For the second year ... with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide our safe, ...
(Date:2/23/2017)... ... , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased to announce KLS ... longtime supporter of the event. , "We are pleased that KLS Martin is joining ... 2017 ACPA President. "KLS Martin has a long track record of support of the ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 24, 2017 Medical information groups within ... their self-service capabilities to manage inquiries from external ... New research from consulting leader Best Practices, ... self-service website portals where HCPs can sign on ... of many findings to emerge from the new ...
(Date:2/24/2017)... ITL Limited, ( ASX: ITD ), ... für das zum 31. Dezember 2016 endende Halbjahr ... vorlegen zu können. Eine vollständige Präsentation „Ergebnisse von ... Sie hier . Glanzpunkte ... 2015: 1,04 Millionen USD; +104 %) Gewinn je ...
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 ... gives comprehensive insights on the various drugs ... The report covers all the drugs that ... Preclinical & Clinical). The pipeline focuses on ... small molecules, antibodies, stem cell therapies, recombinant ...
Breaking Medicine Technology: